A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care

NCT ID: NCT06907589

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-13

Study Completion Date

2026-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Healthy Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motor Data Analysis for Healthy Subjects

All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement

Group Type EXPERIMENTAL

Motor Data Analysis

Intervention Type DEVICE

The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.

Motor Data Analysis for patients with Parkinson's disease

All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement

Group Type EXPERIMENTAL

Motor Data Analysis

Intervention Type DEVICE

The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motor Data Analysis

The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult subjects, both sexes, aged 50-80 years old
* MMSE score \>= 24 absence of olfactory deficit detected on IOIT olfactory test (22). Age class 50-59 years: normal with score \<=5; age class 60-69 years: normal with score \<=6; age class \> 70 years: normal with score \<=7
* absence of neurological diseases
* absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
* expression of informed consent to participate in the study

* adult subjects, both sexes, 50-80 years of age
* MMSE score \>= 24
* subjects with Parkinson's disease in the absence of motor fluctuations and dyskinesias, or subjects with Parkinson's disease with mild motor fluctuations throughout the day, but to be examined in the ON phase and in the absence of dyskinesias
* Hoehn and Yahr stage 1, 2, 3
* absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
* expression of informed consent to participate in the study

Exclusion Criteria

* denial of informed consent to participate in the study
* Presence of olfactory deficit detected on IOIT olfactory test. Age class 50-59 years: hyposmia with score \>=6; age class 60-69 years: hyposmia with score \>=7; age class \> 70 years: hyposmia with score \>=8
* body weight greater than 120 kg
* insufficient degree of cooperation
* malignant neoplasm in progress or with negative follow-up of less than 6 years
* structured joint stiffness in the upper and/or lower extremities preventing proper execution of movements
* paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury
* mono/multi/poly sensory and/or motor neuropathy
* chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
* vertiginous syndromes in the acute phase
* neurodegenerative diseases
* fever
* venous thrombosis
* cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
* spinal or joint pain of various etiologies that may affect the performance of motor exercises
* positive history of recurrent acute cervico-brachialgia and/or lumbosciatica

* Denial of informed consent to participate in the study
* Hoenn and Yahr stage 4, 5
* Patient who needs to use an aid (cane or walker) while walking or cannot walk unless aided by a person
* body weight greater than 120 kg
* insufficient degree of cooperation
* malignant neoplasm in place or with negative follow-up of less than 6 years
* structured joint stiffness in the upper and/or lower extremities that prevents proper execution of movements
* paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury mono/multi/poly sensory and/or motor neuropathy
* chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
* vertiginous syndromes in the acute phase
* neurodegenerative diseases, excluding Parkinson's disease
* fever
* venous thrombosis
* cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
* spinal or joint pain of various etiologies that may affect the performance of motor exercises
* positive history of recurrent acute cervico-brachialgia and/or low back pain
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Filippo Cavallo

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale Santa Maria Annunziata AUSL Toscana Centro

Bagno a Ripoli, Firenze, Italy

Site Status RECRUITING

Azienda Ospedaliero Universitaria Careggi

Florence, , Italy

Site Status RECRUITING

IRCCS Fondazione Don Carlo Gnocchi Firenze

Florence, , Italy

Site Status RECRUITING

Ospedale Apuane AUSL Toscana Nord Ovest

Massa, , Italy

Site Status RECRUITING

IRCCS Istituto Auxologico Italiano, Ospedale San Luca

Milan, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Filippo Cavallo

Role: CONTACT

+390552758663

Erika Rovini

Role: CONTACT

+390553758663

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paola Vanni

Role: primary

+390552313862

Silvia Ramat

Role: primary

+390557947956

Gemma Lombardi

Role: primary

+3905557393917

Carlo Maremmani

Role: primary

+3905854931

Andrea Ciammola

Role: primary

+39026191129

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OLIMPIA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Parkinson's Disease Progression Study
NCT06219629 ACTIVE_NOT_RECRUITING